Market Tracker

09/21 4:18pm ET

Novartis AG (NYSE:NVS)

83.01
Delayed Data
As of 4:00pm ET
 +0.21 / +0.25%
Today’s Change
77.04
Today|||52-Week Range
98.52
-12.09%
Year-to-Date
Top Research Reports for Facebook, Walmart & Novartis
1:23pm / Zacks.com - Paid Partner Content
Celldex (CLDX) Initiates Subcutaneous Skin Disorder Drug Study
Sep 14 / Zacks.com - Paid Partner Content
BeiGene (BGNE) Scores Third FDA Nod for Brukinsa in Lymphoma
Sep 16 / Zacks.com - Paid Partner Content
Why Regenxbio Stock Is Way Up Today
Sep 13 / MotleyFool.com - Paid Partner Content
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Sep 16 / Zacks.com - Paid Partner Content
BeiGene's (BGNE) BLA for Tislelizumab in ESCC Accepted by FDA
Sep 13 / Zacks.com - Paid Partner Content
Cigarette group takes control of asthma inhaler maker
Sep 16 / CNN.com - Paid Partner Content
3 Red-Hot Healthcare Stocks to Buy in September
Sep 09 / MotleyFool.com - Paid Partner Content
3 Top Chinese Stocks to Watch in September
Sep 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close82.80
Today’s open83.30
Day’s range82.98 - 83.90
Volume1,803,847
Average volume (3 months)1,786,891
Market cap$186.9B
Data as of 4:00pm ET, 09/21/2021

Growth & Valuation

Earnings growth (last year)+15.91%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+2.95%
P/E ratio21.0
Price/Sales4.43
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.49+0.46%
MRKMerck+0.01+0.01%
AZNAstraZeneca+0.61+1.04%
NVONovo Nordisk+2.13+2.14%
Data as of 4:09pm ET, 09/21/2021

Financials

Next reporting dateOctober 26, 2021
EPS forecast (this quarter)$1.62
Annual revenue (last year)$48.9B
Annual profit (last year)$8.1B
Net profit margin16.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts